Midazolam Maleate

马来酸咪达唑仑

Report date: 2025/03/27 16:28:18
NME

Base Information

Drug NameMidazolam Maleate
Drug Alias NameMidafresaBuccolamDormicumNVD-301Ro-21-3981/001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersAnesthesia
Global Approved IndicationsSleep Initiation and Maintenance DisordersAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryNetherlands
Original Approved Date1985/11/27
Country/TerritoryNetherlandsUnited KingdomEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuraxpharmOrpha-Devel Handels Und Vertriebs GmbhCheplapharm Arzneimittel Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance DisordersAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN05CD08
Related LinksWikipediaDrugBankKEGG